A combined large-scale meta-analysis identifies COG6 as a novel shared risk locus for rheumatoid arthritis and systemic lupus erythematosus. Issue 1 (18th May 2016)

• Record Type: Journal Article
• Authors: Márquez, Ana; Vidal-Bralo, Laura; Rodríguez-Rodríguez, Luis; González-Gay, Miguel A; Balsa, Alejandro; González-Álvaro, Isidoro; Carreira, Patricia; Ortego-Centeno, Norberto; Ayala-Gutiérrez, María M; García-Hernández, Francisco José; González-Escribano, M Francisca; Sabio, José Mario; Tolosa, Carles; Suárez, Ana; González, Antonio; Padyukov, Leonid; Worthington, Jane; Vyse, Timothy; Alarcón-Riquelme, Marta E; Martín, Javier
• Is Part Of: Annals of the rheumatic diseases. Volume 76:Issue 1(2017)
• Page Start: 286
• Page End: 294
• Publication Date: 2016-05-18
• Subjects: Rheumatoid Arthritis -- Systemic Lupus Erythematosus -- Gene Polymorphism; Rheumatism -- Periodicals; 616.723005
• DOI: 10.1136/annrheumdis-2016-209436
• Languages: English
• ISSNs: 0003-4967

Abstract

Abstract : Objectives: During the last years, genome-wide association studies (GWASs) have identified a number of common genetic risk factors for rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). However, the genetic overlap between these two immune-mediated diseases has not been thoroughly examined so far. The aim of the present study was to identify additional risk loci shared between RA and SLE. Methods: We performed a large-scale meta-analysis of GWAS data from RA (3911 cases and 4083 controls) and SLE (2237 cases and 6315 controls). The top-associated polymorphisms in the discovery phase were selected for replication in additional datasets comprising 13 641 RA cases and 31 921 controls and 1957 patients with SLE and 4588 controls. Results: The rs9603612 genetic variant, located nearby the COG6 gene, an established susceptibility locus for RA, reached genome-wide significance in the combined analysis including both discovery and replication sets (p value=2.95E−13). In silico expression quantitative trait locus analysis revealed that the associated polymorphism acts as a regulatory variant influencing COG6 expression. Moreover, protein–protein interaction and gene ontology enrichment analyses suggested the existence of overlap with specific biological processes, specially the type I interferon signalling pathway. Finally, genetic correlation and polygenic risk score analyses showed cross-phenotype associations between RA and SLE. Conclusions: In conclusion, we have identified a new risk locus shared between RA and SLE through a meta-analysis including GWAS datasets of both diseases. This study represents the first comprehensive large-scale analysis on the genetic overlap between these two complex disorders.